NKGen Biotech (NKGN) Institutional Ownership → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free NKGN Stock Alerts $1.61 -0.37 (-18.69%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for NKGen Biotech (NYSE:NKGN)CurrentInstitutional OwnershipPercentage76.17%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.51MNumber ofInstitutional Sellers(last 12 months)0 Get NKGN Insider Trade Alerts Want to know when executives and insiders are buying or selling NKGen Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << NKGen Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/14/2024 University of Chicago550,000$1.51M2.1%N/A2.513% (Data available from 1/1/2016 forward) NKGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NKGN shares? During the previous two years, the following institutional investors and hedge funds held shares of NKGen Biotech shares: University of Chicago ($1.51M).Learn more on NKGN's institutional investors. What percentage of NKGen Biotech stock is owned by institutional investors? 76.17% of NKGen Biotech stock is owned by institutional investors. Learn more on NKGN's institutional investor holdings. Which institutional investors have been buying NKGen Biotech stock? The following institutional investors have purchased NKGen Biotech stock in the last 24 months: University of Chicago ($550K). How much institutional buying is happening at NKGen Biotech? Institutional investors have bought a total of 550,000 shares in the last 24 months. This purchase volume represents approximately $1.51M in transactions. Related Companies: SAB Biotherapeutics Major Shareholders OKYO Pharma Major Shareholders Dyadic International Major Shareholders Cidara Therapeutics Major Shareholders Estrella Immunopharma Major Shareholders Quince Therapeutics Major Shareholders Brainstorm Cell Therapeutics Major Shareholders Cyclo Therapeutics Major Shareholders Protara Therapeutics Major Shareholders IN8bio Major Shareholders This page (NYSE:NKGN) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets4 Cryptos BETTER than BitcoinTrue Market InsidersHas Jeff Bezos Found the Next Nvidia?InvestorPlaceGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
